Evidence map›Paper›PMID 26416658›Full record

ArticleThe Journal of infectious diseases2016

Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis.

Andre Kubler, Christer Larsson, Brian Luna, Bruno B Andrade, Eduardo P Amaral, Michael Urbanowski, Marlene Orandle, Kevin Bock, Nicole C Ammerman, Laurene S Cheung and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Cathepsin K: The Action in and Beyond Bone.Frontiers in cell and developmental biology · 2020
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Frontiers in immunology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 4 countries.

Andre KublerInfectious Diseases and Immunity, Imperial College London Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore.
Christer LarssonDepartment of Molecular Biology, Umeå University, Sweden.
Brian LunaCenter for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore.
Bruno B AndradeImmunobiology Section, Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
Eduardo P AmaralImmunobiology Section, Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
Michael UrbanowskiCenter for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore.
Marlene OrandleInfectious Diseases Pathogenesis Section, Comparative Medicine Branch, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
Kevin BockInfectious Diseases Pathogenesis Section, Comparative Medicine Branch, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
Nicole C AmmermanCenter for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore.
Laurene S CheungCenter for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore.
Kathryn WingleeCenter for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore.
Marc HalushkaDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore.
Jin Kyun ParkDivision of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, South Korea.
Alan SherImmunobiology Section, Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
Jon S FriedlandInfectious Diseases and Immunity, Imperial College London.
Paul T ElkingtonInfectious Diseases and Immunity, Imperial College London Faculty of Medicine, University of Southampton, United Kingdom.
William R BishaiCenter for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore.
Johns Hopkins University · USNational Institute of Allergy and Infectious Diseases · USJohns Hopkins Medicine · USImperial College London · GBNational Institutes of Health · USSeoul National University Hospital · KRUmeå University · SEUniversity of Southampton · GB

Funding

Training Program in Cellular and Molecular MedicineT32GM008752 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI RAO, RAJINI · 2000 to 2019
$11.7M
Regulation Of Immunopathology In Bacterial And Parasitic DiseaseZIAAI000843 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SHER, ALAN · 2009 to 2022
$11.1M
Mycobacterium tuberculosis Survival Regulatory GenesR01AI037856 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BISHAI, WILLIAM RAMSES · 1997 to 2020
$7.2M
GENE REGULATION AND VIRULENCE IN TB AND MACR01AI036973 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BISHAI, WILLIAM RAMSES · 1999 to 2014
$5.7M
PK/PD Evaluation Resistance Development in Caseating GranulomaR01AI079590 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BISHAI, WILLIAM RAMSES · 2008 to 2011
$2.5M
Targeting matrix metalloproteinases to limit immunopathology in airborne infectioR33AI102239 · NIAID · UNIVERSITY OF SOUTHAMPTON · PI ELKINGTON, PAUL TIMOTHY · 2014 to 2016
$1.1M
Intramural NIH HHSNIAID NIH HHS R01 AI036973NIAID NIH HHS R01 AI037856NIAID NIH HHS R01 AI 079590NIAID NIH HHS R01 AI079590NIAID NIH HHS R33 AI102239NIGMS NIH HHS T32 GM008752PHS HHS R33 A1102239
6 · The paper itself

Abstract

Cavitation in tuberculosis enables highly efficient person-to-person aerosol transmission. We performed transcriptomics in the rabbit cavitary tuberculosis model. Among 17 318 transcripts, we identified 22 upregulated proteases. Five type I collagenases were overrepresented: cathepsin K (CTSK), mast cell chymase-1 (CMA1), matrix metalloproteinase 1 (MMP-1), MMP-13, and MMP-14. Studies of collagen turnover markers, specifically, collagen type I C-terminal propeptide (CICP), urinary deoxypyridinoline (DPD), and urinary helical peptide, revealed that cavitation in tuberculosis leads to both type I collagen destruction and synthesis and that proteases other than MMP-1, MMP-13, and MMP-14 are involved, suggesting a key role for CTSK. We confirmed the importance of CTSK upregulation in human lung specimens, using immunohistochemical analysis, which revealed perigranulomatous staining for CTSK, and we showed that CTSK levels were increased in the serum of patients with tuberculosis, compared with those in controls (3.3 vs 0.3 ng/mL; P = .005).

Indexed as

AnimalsCathepsin KCollagenCollagenasesDisease Models, AnimalFemaleGene Expression ProfilingImmunohistochemistryLungRabbitsTuberculosis, PulmonaryCathepsin KCollagenCollagenasescathepsin KcollagencollagenolysisrabbitRNAseqtuberculosis

Identifiers

PMID26416658
PMCPMC4721912
OpenAlexW2229317465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.